Pyridylmethylthio derivatives as VEGF inhibitors. Part 1

Optimization from compound 4a, having intramolecular S–O nonbonded interaction, led to discover compounds 4m and 4n. They were highly active in vitro (VEGF induced HUVEC proliferation assay) and showed efficacies in three disease models in vivo (cancer, RA, AMD).

Figure optionsDownload as PowerPoint slide